v3.26.3
Condensed Consolidated Statements of Stockholders’ Deficit - USD ($)
$ in Millions
Total
Common Stock
Additional paid-in capital
Share repurchase commitment
Accumulated other comprehensive loss
Accumulated deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   125,000,000        
Balance at beginning of period at Dec. 31, 2024 $ (337) $ 62 $ 90 $ (10) $ (36) $ (443)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 47         47
Other comprehensive income 1       1  
Common stock issued (in shares)   1,000,000        
Common stock issued 1          
Common stock repurchased and canceled (in shares)   (1,000,000)        
Common stock repurchased and canceled (11)         (10)
Stock-based compensation 6   6      
Share repurchase liability movement, net 10     10    
Settlement of tax on equity awards (3)   (3)      
Balance at end of period (in shares) at Mar. 31, 2025   125,000,000        
Balance at end of period at Mar. 31, 2025 (285) $ 62 93 0 (35) (406)
Balance at beginning of period (in shares) at Dec. 31, 2024   125,000,000        
Balance at beginning of period at Dec. 31, 2024 (337) $ 62 90 (10) (36) (443)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 108          
Other comprehensive income 3          
Balance at end of period (in shares) at Sep. 30, 2025   125,000,000        
Balance at end of period at Sep. 30, 2025 (207) $ 62 109 0 (32) (346)
Balance at beginning of period (in shares) at Mar. 31, 2025   125,000,000        
Balance at beginning of period at Mar. 31, 2025 (285) $ 62 93 0 (35) (406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 18         18
Other comprehensive income 2       2  
Stock-based compensation 8   8      
Balance at end of period (in shares) at Jun. 30, 2025   125,000,000        
Balance at end of period at Jun. 30, 2025 (257) $ 62 101 0 (33) (388)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 42         42
Other comprehensive income 0          
Common stock issued 1   1      
Stock-based compensation 6   6      
Balance at end of period (in shares) at Sep. 30, 2025   125,000,000        
Balance at end of period at Sep. 30, 2025 $ (207) $ 62 109 0 (32) (346)
Balance at beginning of period (in shares) at Dec. 31, 2025 125,000,000 125,000,000        
Balance at beginning of period at Dec. 31, 2025 $ (98) $ 62 112 0 (30) (243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock canceled and exchanged as part of U.S. Domestication 0 $ (62) 62      
Net income $ 89         89
Common stock issued (in shares)   1,000,000        
Common stock repurchased and canceled (in shares) (3,974,153) (4,000,000)        
Common stock repurchased and canceled $ (126)         (126)
Stock-based compensation 9   9      
Settlement of tax on equity awards (21)   (21)      
Other 3   3      
Balance at end of period (in shares) at Mar. 31, 2026   122,000,000        
Balance at end of period at Mar. 31, 2026 $ (144) $ 0 165 0 (29) (280)
Balance at beginning of period (in shares) at Dec. 31, 2025 125,000,000 125,000,000        
Balance at beginning of period at Dec. 31, 2025 $ (98) $ 62 112 0 (30) (243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 348          
Other comprehensive income $ 4          
Balance at end of period (in shares) at Sep. 30, 2026 118,000,000 118,000,000        
Balance at end of period at Sep. 30, 2026 $ (60) $ 0 163 0 (26) (197)
Balance at beginning of period (in shares) at Mar. 31, 2026   122,000,000        
Balance at beginning of period at Mar. 31, 2026 (144) $ 0 165 0 (29) (280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 122         122
Other comprehensive income 1       1  
Common stock issued (in shares)   1,000,000        
Common stock repurchased and canceled (in shares)   (5,000,000)        
Common stock repurchased and canceled (176)         (176)
Stock-based compensation 11   11      
Settlement of tax on equity awards (24)   (24)      
Other 2   2      
Balance at end of period (in shares) at Jun. 30, 2026   118,000,000        
Balance at end of period at Jun. 30, 2026 (208) $ 0 155 0 (28) (334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 137         137
Other comprehensive income 3       3  
Stock-based compensation 8   8      
Other $ 1   1      
Balance at end of period (in shares) at Sep. 30, 2026 118,000,000 118,000,000        
Balance at end of period at Sep. 30, 2026 $ (60) $ 0 $ 163 $ 0 $ (26) $ (197)